Roland Nardone, Advocate for Cell-Line Authentication, Dies

The Catholic University of America professor was also known for his summer workshops on the latest techniques.

Jul 11, 2018
Kerry Grens
Roland Nardone
courtesy francis j. collins funeral home

Roland Nardone, a longtime professor at Catholic University of America who was one of the loudest voices in speaking out against cell-line contamination, died June 20. He was 90 years old.

Nardone spent more than 50 years at Catholic University, and in the later part of his career he advocated for best practices in authenticating cell lines and avoiding contamination and misidentification in tissue cultures. A founding member of the International Cell Line Authentication Committee, Nardone saw the National Institutes of Health adopt guidelines in 2016 for authentication protocols that reflected those he and his collaborators had pushed for.

“That was a gigantic service to science that probably was his biggest contribution,” says John Golin, a professor at Catholic University who had been hired by Nardone in the 1980s.

Nardone was born in New York and was a precocious student, having finished his PhD at Fordham University in 1951 at age 23. As a professor at Catholic University, Nardone studied protein synthesis, among other cell biology topics. But it was his workshops on life science techniques that remain one of his career’s most important achievements, James Greene, a professor at Catholic University, tells The Scientist.

In the 1980s, as Nardone was ending his research, he saw a need for investigators to learn new methods that were being developed, such as fluorescence-activated cell sorting (FACS). Nardone applied for a grant to get a FACS facility set up at Catholic University—one of the first outside the National Institutes of Health—and started training scientists on how to use it.

Around the same time, Nardone developed the Center for Advanced Training at Catholic University in 1983 that holds one-week-long summer workshops on various techniques. “I think maybe because of all the talents associated with his precociousness he also had prescience to be able to foresee which new technology would become more important for scientists,” says Greene.

Nardone retired in the 1990s, but did not stop working. In 2005, he took up another cause for improving research: cell-line contamination, the widespread problem of cells in culture not being the ones scientists think they are.

His 2007 letter to the US Department of Health and Human Services detailing his concerns and outlining solutions is lauded by the cell-line authentication community as having had a critical role in NIH’s later decision to push for authentication. “Through Roland’s leadership and inspiration to other leading biomedical scientists some significant breakthroughs have finally been achieved,” according to a memorial on the European Collection of Authenticated Cell Cultures’s website.

“Roland’s work shed a beacon of light on the stormy sea of cross-contaminated cell lines,” the International Cell Line Authentication Committee writes on its website. “We will miss our lighthouse and the light he shed on this important cell culture problem.”

Nardone is survived by his wife of 67 years, four children, and several grandchildren and great-grandchildren.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb


Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!